Author:
Woodworth Thasia G.,den Broeder Alfons A.
Reference13 articles.
1. Smolen JS, Breedveld FC, Burmester GR, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Annals of the Rheumatic Diseases.
2. Singh JA, Furst DE, Bharat A, et al. 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 64; 625–639.
3. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs;Smolen;Annals of the Rheumatic Diseases,2013
4. Pope JE, Haraoui B, Rampakakis E, et al Treating to a target in established active rheumatoid arthritis patients receiving a tumor necrosis factor inhibitor: results from a real-world cluster-randomized adalimumab trial. Arthritis Care Res (Hoboken) 65; 1401–1409.
5. Conventional DMARD therapy and improvement of disease activity in a cohort of rheumatoid arthritis patients treated under treat to target recommendations;Santos-Moreno;Annals of the Rheumatic Diseases,2015
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献